Riskpilot← Back to searchSign inGet full accessDENAMED AS
ASActiveOrg 979221754Østensjøveien 27, 0661 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 19970 employeeswww.denamed.no
Revenue 2025
NOK 10,7M
+22% vs 2024
EBITDA margin
3.7%
+164% vs 2024
Equity ratio
61.7%
Financial strength
Net profit 2025
NOK 348K
+191% vs 2024
| Revenue | NOK 10,7M | +22% |
| EBITDA | NOK 396K | +164% |
| Net profit | NOK 348K | +191% |
| Total assets | NOK 9,5M | +48% |
| Equity | NOK 5,9M | +6% |
| Employees | 0 | — |
Legal name
DENAMED AS
Org number
979221754
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
25. august 1997
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Company purpose
Import og handel av legemidler og andre produkter til bruk i tannbehandling og annen relatert helsebehandling.
Address
Østensjøveien 27, 0661 Oslo
Website
www.denamed.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 929 | 3 597 | 4 135 | 4 608 | 5 452 | 5 137 | 5 273 | 5 765 | 6 146 | 6 146 | 5 450 | 8 084 | 8 241 | 8 814 | 10 742 |
| Staff expenses | −318 | −252 | −243 | −243 | −224 | −108 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 1 242 | 449 | 640 | 1 466 | 1 374 | 973 | 548 | 1 383 | 1 303 | 539 | −59 | 1 446 | 1 272 | −617 | 396 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 242 | 449 | 640 | 1 466 | 1 374 | 973 | 548 | 1 383 | 1 303 | 539 | −59 | 1 446 | 1 272 | −617 | 396 |
| Net financials | 52 | 17 | 27 | −25 | −7 | 48 | −42 | −18 | 20 | 47 | −199 | −1 | 57 | 128 | 50 |
| Profit before tax | 1 294 | 465 | 667 | 1 441 | 1 367 | 1 021 | 506 | 1 365 | 1 323 | 585 | −259 | 1 445 | 1 329 | −489 | 447 |
| Tax | 363 | 130 | 187 | 389 | 369 | 256 | 121 | 314 | 291 | 129 | −57 | 318 | 292 | −107 | 98 |
| Net profit | 931 | 335 | 480 | 1 052 | 998 | 766 | 385 | 1 051 | 1 032 | 456 | −202 | 1 127 | 1 037 | −382 | 348 |
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 165 | 2 248 | 3 099 | 5 139 | 6 811 | 7 190 | 7 319 | 7 346 | 8 598 | 6 456 | 4 267 | 5 587 | 6 947 | 6 434 | 9 531 |
| Equity | 1 396 | 1 731 | 2 212 | 3 264 | 4 261 | 5 027 | 5 412 | 6 463 | 3 495 | 3 952 | 3 750 | 4 877 | 5 914 | 5 532 | 5 880 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 769 | 517 | 887 | 1 875 | 2 550 | 2 163 | 1 907 | 883 | 5 103 | 2 504 | 518 | 710 | 1 033 | 902 | 3 651 |
| Total debt | 769 | 517 | 887 | 1 875 | 2 550 | 2 163 | 1 907 | 883 | 5 103 | 2 504 | 518 | 710 | 1 033 | 902 | 3 651 |
EBITDA margin
3.7%
This company
15.8%
Market median
-77% vs market
20112025
Equity ratio
61.7%
This company
38.2%
Market median
+62% vs market
20112025
Return on equity
5.9%
This company
18.4%
Market median
-68% vs market
20112025
Net profit margin
3.2%
This company
8.1%
Market median
-60% vs market
20112025
Asset turnover
1.13×
This company
1.12×
Market median
+1% vs market
20112025
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20112025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-02-01 – 2025-01-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-02-01 – 2024-01-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-02-01 – 2023-01-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-02-01 – 2022-01-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-02-01 – 2021-01-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2019-02-01 – 2020-01-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2018-02-01 – 2019-01-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2017-02-01 – 2018-01-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2016-02-01 – 2017-01-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2015-02-01 – 2016-01-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2014-02-01 – 2015-01-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2013-02-01 – 2014-01-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2012-02-01 – 2013-01-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2011-02-01 – 2012-01-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2011-01-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Plandent As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Plandent As
DENAMED AS Board members of DENAMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Laila Heidi Mani | Board of Directors | 0 companies |
| Ragnar Pettersson | Chairman | 0 companies |